Teva Pharmaceutical Industries
TEVA
#493
Rank
$49.71 B
Marketcap
$42.61
Share price
1.99%
Change (1 day)
77.76%
Change (1 year)

P/S ratio for Teva Pharmaceutical Industries (TEVA)

P/S ratio as of November 2026 (TTM): 2.86

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.38. At the end of 2026 the company had a P/S ratio of 2.23.

P/S ratio history for Teva Pharmaceutical Industries from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.238.55%
20252.0631.94%
20241.56108.57%
20230.747710.16%
20220.678721.97%
20210.5564-10.99%
20200.6251-4.94%
20190.6576-26.92%
20180.89984.81%
20170.8585-48.89%
20161.68-44.21%
20153.0125.69%
20142.4044.02%
20131.666.12%
20121.57-19.45%
20111.95-32.94%
20102.90-18.91%
20093.584.86%
20083.41-14.5%
20073.9936.19%
20062.93-44.67%
20055.3035.81%
20043.90-18.84%
20034.8121.21%
20023.974.34%
20013.80

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.35 87.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.62-8.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.98-30.85%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
5.44 90.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.72 65.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.27-20.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
3.51 22.77%๐Ÿ‡ฎ๐Ÿ‡ณ India